Estelle Dogbo
CEO & Co-Founder of BioVana Research, leads African genomics and pharmacogenomics initiatives, bridging science, equity, and innovation in global pharmaceutical R&D.
Estelle Dogbo is the Co-Founder & CEO of BioVana Research, an organization dedicated to advancing health data and biobank infrastructure across Africa to power global biomedical innovation. With a career spanning leading roles at Sanofi, Roche, 54gene, and as Co-Founder/COO of Syndicate Bio, Estelle has been at the forefront of genomics and precision medicine in Africa.
She has designed and scaled molecular laboratories, biobanks, and clinical research partnerships that have enabled pharmacogenomic discovery and more inclusive clinical trials. Estelle is recognized for her ability to bridge science, data, and strategy, ensuring that African genomic diversity informs drug development and pharmaceutical R&D pipelines.
She holds a Master’s degree in Cell Biology from Paris Sorbonne Nord University and an MBA in Biotechnology Management from the IONIS STM. Beyond her work with BioVana, Estelle is a member of the AI for Developing Country Forum, a United Nations initiative focused on addressing disparities in AI adoption and advancing equitable access to emerging technologies.
Through BioVana, she continues to build platforms that accelerate pharmacogenomics research while embedding principles of equity, ethics, and sustainability in healthcare innovation.
